Literature DB >> 3095137

The role of surgery in transmitting "post-transfusion hepatitis".

C Gallo, G B Gaeta, B Galanti, G Giusti.   

Abstract

The role of surgery as an additional risk in transmitting "post-transfusion" hepatitis was investigated in a retrospective study on acute hepatitis occurring in 77 transfused patients, 293 transfused and operated patients and 243 hepatitis cases with history of surgery without transfusion. Hepatitis A patients admitted to the same centres in the same period were utilized as controls. In transfused patients the percentage of NANB hepatitis was higher than that of type B (61.0% vs. 36.4%), while in the operated not transfused group the percentage of type B was twice that of type NANB (63.4% vs. 32.5%). In transfused and operated cases intermediate values were observed. The age-adjusted measures of association between exposures and the different hepatitis types showed a lack of effect of transfusion and a dominant role of surgery in transmitting type B hepatitis. In contrast, NANB "post-transfusional" cases were actually a mixture of post-transfusional and post-surgical cases, since both these exposures were found to be significantly associated with the disease. Our results suggest that studies on the incidence and the etiology of post-transfusion hepatitis should take into account the risk of surgical exposure which might have occurred.

Entities:  

Mesh:

Year:  1986        PMID: 3095137     DOI: 10.1007/bf00157017

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  10 in total

1.  The estimation of synergy or antagonism.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

2.  Standardization of risk ratios.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1972-12       Impact factor: 4.897

3.  Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study.

Authors:  Y E Cossart; S Kirsch; S L Ismay
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

4.  Prospective study of posttransfusion hepatitis in cardiac surgery patients receiving only blood or also blood products.

Authors:  F Tremolada; F Chiappetta; F Noventa; C Valfrè; G Ongaro; G Realdi
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

5.  Post-transfusion hepatitis: analysis of risk factors.

Authors:  R D Aach; F B Hollinger; W Szmuness; J W Mosley; G L Gitnick; R A Kahn; C E Stevens; D Goodwin; J M Weiner
Journal:  Acta Haematol Pol       Date:  1980 Jul-Sep

6.  Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.

Authors:  R D Aach; W Szmuness; J W Mosley; F B Hollinger; R A Kahn; C E Stevens; V M Edwards; J Werch
Journal:  N Engl J Med       Date:  1981-04-23       Impact factor: 91.245

7.  [Adjustment and standardization: 2 concepts].

Authors:  C Lapointe; P M Bernard
Journal:  Rev Epidemiol Sante Publique       Date:  1982       Impact factor: 1.019

8.  Interpretation and estimation of summary ratios under heterogeneity.

Authors:  S Greenland
Journal:  Stat Med       Date:  1982 Jul-Sep       Impact factor: 2.373

Review 9.  Post-transfusion hepatitis: current perspectives.

Authors:  R D Aach; R A Kahn
Journal:  Ann Intern Med       Date:  1980-04       Impact factor: 25.391

10.  Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen.

Authors:  A Tateda; K Kikuchi; Y Numazaki; R Shirachi; N Ishida
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

  10 in total
  3 in total

Review 1.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

2.  Contamination of syringes.

Authors:  P M Kempen
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

3.  Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections.

Authors:  G B Gaeta; M Rapicetta; C Sardaro; A Spadaro; F Chionne; A M Freni; A Ajello; A Costantino; G Giusti
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.